These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2448943)

  • 21. Phyllodes type of atypical prostatic hyperplasia.
    Attah EB; Nkposong EO
    J Urol; 1976 Jun; 115(6):762-4. PubMed ID: 59819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Possibilities of the quantitative structural analysis of prostate biopsies].
    Bartsch G; Rohr HP
    Bull Schweiz Akad Med Wiss; 1977 May; 33(1-3):99-109. PubMed ID: 69463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Ultrastructural studies of the detrusor in patients with benign prostatic hyperplasia].
    Loran OB; Vishnevskiĭ AE; Sekamova SM
    Urol Nefrol (Mosk); 1996; (4):27-31. PubMed ID: 8928345
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of stromal tissue in benign prostatic hyperplasia: morphological, immunofluorescence and endocrinological investigations.
    Bartsch G; Brüngger A; Schweikert U; Hintner H; Stanzl U; Marth C; Daxenbichler G; Rohr HP
    Prog Clin Biol Res; 1984; 145():159-79. PubMed ID: 6201873
    [No Abstract]   [Full Text] [Related]  

  • 25. Rho kinase activation mediates adrenergic and cholinergic smooth muscle contractile responses in the mouse prostate gland.
    White CW; Short JL; Ventura S
    Eur J Pharmacol; 2013 Dec; 721(1-3):313-21. PubMed ID: 24055190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis.
    Shapiro E; Hartanto V; Lepor H
    J Urol; 1992 Apr; 147(4):1167-70. PubMed ID: 1372663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smooth muscle tumors of the vagina.
    Tavassoli FA; Norris HJ
    Obstet Gynecol; 1979 Jun; 53(6):689-93. PubMed ID: 450336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal cell hyperplasia of the prostate.
    Cleary KR; Choi HY; Ayala AG
    Am J Clin Pathol; 1983 Dec; 80(6):850-4. PubMed ID: 6195916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between morphometric differences and norepinephrine content in benign prostatic hyperplasia.
    Ishigooka M; Hashimoto T; Hayami S; Suzuki Y; Sasagawa I; Nakada T
    Prostate; 1996 Jun; 28(6):385-91. PubMed ID: 8650076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlations between parameters in pressure-flow analysis and histological compositions in prostate in patients with benign prostatic hyperplasia.
    Ichiyanagi O; Nakada T
    Urol Int; 1997; 59(3):154-60. PubMed ID: 9428431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 4. Steroid pathophysiology of BPH. Correlative morphological and biochemical investigations on the stromal tissue of the human prostate.
    Bartsch G; Daxenbichler G; Rohr HP
    J Steroid Biochem; 1983 Jul; 19(1A):147-54. PubMed ID: 6193337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical stromal smooth muscle hyperplasia of prostate.
    Young RH
    Urology; 1988 Sep; 32(3):283. PubMed ID: 3413921
    [No Abstract]   [Full Text] [Related]  

  • 33. Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia.
    Chon JK; Borkowski A; Partin AW; Isaacs JT; Jacobs SC; Kyprianou N
    J Urol; 1999 Jun; 161(6):2002-8. PubMed ID: 10332490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats.
    Arruzazabala ML; Más R; Molina V; Noa M; Carbajal D; Mendoza N
    Drugs R D; 2006; 7(4):233-41. PubMed ID: 16784248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial proliferations in prostatic stromal tumors of uncertain malignant potential (STUMP).
    Nagar M; Epstein JI
    Am J Surg Pathol; 2011 Jun; 35(6):898-903. PubMed ID: 21572264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of prostatic smooth muscle contractility by intracellular second messengers: implications for the conservative treatment of benign prostatic hyperplasia.
    Eckert RE; Schreier U; Drescher P; Madsen PO; Derouet H; Becht E; Steffens J; Ziegler M
    Urol Int; 1995; 54(1):6-21. PubMed ID: 7539557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytoskeletal and cytocontractile protein composition of stromal tissue in normal, hyperplastic, and neoplastic human prostate. An immunocytochemical study with monoclonal antibodies.
    Castellucci E; Prayer-Galetti T; Roelofs M; Pampinella F; Faggian L; Gardiman M; Pagano F; Sartore S
    Ann N Y Acad Sci; 1996 Apr; 784():496-508. PubMed ID: 8651605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate.
    Zhang Y; Nojima S; Nakayama H; Jin Y; Enza H
    Oncol Rep; 2003; 10(1):207-11. PubMed ID: 12469170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological characteristics of smooth muscle in benign prostatic hyperplasia and normal prostatic tissue.
    Kitada S; Kumazawa J
    J Urol; 1987 Jul; 138(1):158-60. PubMed ID: 2439708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.